Late-onset multiple sclerosis (MS) has poorer prognostic features but often lacks the inflammatory demyelination that is a target for treatment in younger patients. Investigators analysed data from ...

MS patients have increased risks of developing other autoimmune diseases, necessitating careful treatment planning to balance efficacy and risk. Dimethyl fumarate, anti-CD20 antibodies, and ozanimod ...

Kessler Foundation research scientist John DeLuca, Ph.D., has published a clinical article in Journal of Neurology, shedding light on the elusive nature of fatigue in multiple sclerosis (MS) and its ...

Key opinion leaders discuss the challenges associated with step therapy requirements after initially selecting a drug class, the patient factors considered when deciding to switch a patient with ...

For people with the neurodegenerative disease multiple sclerosis (MS), mental health is a major concern. Researchers estimate that depression occurs in up to 50% of people living with MS and is up to ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...

A leading Sligo charity says it is facing a funding gap each year as it delivers essential services to its users. The MS ...